Mercè Pallàs

Also affiliated with Biomedical Research Networking Center on Neurodegenerative Diseases, Institut d'Investigacions Biomèdiques de Barcelona, Universitat de Barcelona

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease”.

Pharmacological Inhibition of Soluble Epoxide Hydrolase as a New Therapy for Alzheimer's Disease

Neurotherapeutics(2020)10.1007/s13311-020-00854-1

N/A

0DataRank · unranked

88 citations

Sandra Codony, Eugènia Pujol, Jun Yang, Rosana Leiva, Carmen Escolano +13 more

Structure‐Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti‐Alzheimer's Agents

ChemMedChem(2022)10.1002/cmdc.202200002

N/A

0DataRank · unranked

12 citations

Bhanwar Singh Choudhary, Júlia Companys‐Alemany, Sukanya Sukanya, Pedro Antonio Ávila-López, Antón L. Martínez +6 more

Uncovering the role of G9a modulatory landscape promoting neuronal plasticity and neuroprotection in Alzheimer's disease

Research Square(2022)10.21203/rs.3.rs-1228952/v1

N/A

0DataRank · unranked

0 citations

Pedro Antonio Ávila-López, Júlia Companys‐Alemany, Gemma Navarro, Laura Marsal-García, Raquel Larramona‐Arcas +8 more

G9a Inhibition Promotes Neuroprotection through GMFB Regulation in Alzheimer’s Disease

Aging and Disease(2024)10.14336/ad.2023.0424-2

N/A

0DataRank · unranked

22 citations

Qizhi Geng, Gemma Navarro, Pedro Antonio Ávila-López, Júlia Companys‐Alemany, Laura Marsal-García +12 more

Microglial pro-inflammatory mechanisms induced by monomeric C-reactive protein are counteracted by soluble epoxide hydrolase inhibitors

International Immunopharmacology(2025)10.1016/j.intimp.2025.114644

N/A

0DataRank · unranked

7 citations

Kristijan Vuraić, Yi Yuan, Sandra Codony, Haydeé Valdés-Quiroz, Carmen Casal +11 more

Beta-hydroxybutyrate counteracts the deleterious effects of a saturated high-fat diet on synaptic AMPAR receptors and cognitive performance

Molecular Metabolism(2025)10.1016/j.molmet.2025.102207

N/A

0DataRank · unranked

4 citations

Christian Griñán‐Ferré, Aida Castellanos, Ernesto Griego, Marc Martínez, Juan D. Navarro‐López +8 more

First-in-class SAM-competitive G9a inhibitor FLAV-27 as a disease-modifying therapy for Alzheimer disease

Molecular Therapy(2025)10.1016/j.ymthe.2025.12.038

N/A

0DataRank · unranked

2 citations

David Valle-Garcia, Carla Barbaraci, Fernando Romero-Becerra, Rohit Kumar Singh, Júlia Jarne-Ferrer +34 more

Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain

Journal of Enzyme Inhibition and Medicinal Chemistry(2025)10.1080/14756366.2025.2574990

N/A

0DataRank · unranked

1 citations

Beatrice Jora, Miriam Santos-Caballero, Qiongju Qiu, Carla Calvó‐Tusell, Celia Escriche +21 more